BioLineRx Market Cap

BioLineRx has a market cap or net worth of 69.06 million as of June 20, 2025. Its market cap has decreased by -68.01% in one year.

Market Cap

69.06M

Enterprise Value

22.04M

Revenue

83.18M

Ranking

n/a

PE Ratio

n/a

Stock Price

2.60

Market Cap Chart

Since February 13, 2007, BioLineRx's market cap has increased from 163.03K to 69.06M, an increase of 42,258.84%. That is a compound annual growth rate of 39.02%.

Market Cap History

Date	Market Cap	% Change
Jun 19, 2025	69.06M	-19.28%
Dec 31, 2024	85.55M	-79.39%
Dec 31, 2023	415.08M	314.57%
Dec 29, 2022	100.12M	-67.59%
Dec 30, 2021	308.95M	60.58%
Dec 31, 2020	192.39M	108.80%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 31, 2017	Pro	Pro
Dec 29, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Teva Pharmaceutical Industries	67.91B
Danel (Adir Yeoshua)	2.52B
Kamada	1.46B
Bait Bakfar	1.09B
BrainsWay	745.97M
Novolog (Pharm-Up 1966)	723.35M
SofWave Medical	716.29M
Ilex Medical	701.05M

Market Cap Rankings